XML 42 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 24, 2022
Cash flows from operating activities:      
Net loss $ (84,672) $ (207,894) $ (139,089)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 23,480 11,311 5,989
Foreign currency losses (gains) (8) (3) 25
(Gain) on investments (10,084) 0 0
Loss on disposal of assets 337 2,914 4,098
Provision for excess and obsolete inventory 33,330 22,276 987
Deferred taxes, net 3,917 (4,620) 0
Stock-based compensation 112,208 154,227 26,858
Changes in operating assets and liabilities:      
Accounts receivable (132,305) (65,817) (508)
Inventories 103 (66,380) (60,559)
Prepaid expenses and other current assets (112,050) (78,906) (121,143)
Deferred expenses (4,936) (5,428) (28,665)
Other assets (8,263) (18,635) 49
Accounts payable 65,270 41,415 41,528
Accrued expenses and other current liabilities 38,467 64,743 37,898
Deferred revenue 18,318 361,518 80,377
Other liabilities (1,189) 20,073 3,908
Net cash provided by (used in) operating activities (58,077) 230,794 (148,247)
Cash flows from investing activities:      
Purchases of property and equipment (42,237) (15,688) (17,950)
Capitalization of internal use software development costs (2,137) (5,638) 0
Proceeds from sale of assets 0 71 0
Proceeds from maturities of marketable securities 340,000 130,000 0
Purchases of marketable securities (48,660) (408,209) 0
Acquisitions of strategic investments (90,485) 0 0
Net cash provided by (used in) investing activities 156,481 (299,464) (17,950)
Cash flows from financing activities:      
Payment for taxes related to net share settlement of stock-based compensation awards (3,181) (26,674) 0
Net proceeds from issuance of common stock under employee stock purchase plan 5,743 2,573 0
Proceeds from issuance of Class A Common Stock 257,985 0 0
Proceeds from exercise of warrants 158,704 0 277,776
Distributions to Symbotic Holdings LLC partners (48,215) 0 0
Net proceeds from equity infusion from the Business Combination 0 0 384,672
Purchase of interest from non-controlling interest 0 0 (300,000)
Net cash provided by (used in) financing activities 371,036 (24,101) 362,448
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4) 232 572
Net increase (decrease) in cash, cash equivalents, and restricted cash 469,436 (92,539) 196,823
Cash, cash equivalents, and restricted cash —beginning of period 260,918 353,457 156,634
Cash, cash equivalents, and restricted cash —end of period 730,354 260,918 353,457
Non-cash activities:      
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 5,818 8,734 0
Transfer of equipment from deferred cost to property and equipment 38,454 0 0
Warrant associated with supplier agreement 12,308 0 0
Preferred Return, Class B-1      
Non-cash activities:      
Preferred Return 0 0 8,130
Preferred Return, Class B      
Non-cash activities:      
Preferred Return $ 0 $ 0 $ 16,065